#MedSky #IDSky #MedEd
Ensitrelvir is now FDA-approved for #COVID19 post exposure prophylaxis in ages 12&up. A 5 day course of the oral antiviral taken within 72 hrs reduces relative risk of symptomatic COVID infection by 67%.
www.nejm.org/doi/full/10....
Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...
